Suppression of the Phenotype of T24 H-ras1 Transformed Cells

  • Demetrios A. Spandidos
Part of the NATO ASI Series book series (NSSA, volume 220)


Many tumors contain activated ras genes (Bos, 1989; Field and Spandidos, 1990). These genes are thought to be involved in the development of these cancers. It would be of great therapeutic value to find ways to prevent these cancer cells growing. Therefore it is of interest to explore methods by which the growth of ras transformed cells is controlled i.e. suppression of cancer phenotype. These studies are more easily undertaken in vitro i.e. in tissue culture systems than in vivo and in this paper we will concentrate on the in vitro studies. A recent review has classified the suppression of ras transformants into three groups (Kuzumaki, 1991). Viz. 1. Those that operate through genetic material (genetical). 2. Those that operate through biological response modifiers (biological) and 3. Drugs (pharmaceutical) (see Table 1).


Tumorigenic Phenotype Growth Inhibitory Substance Chinese Hamster Lung Cell Skeletal Myoblast Differentiation Metallothionin Promoter 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bar-Sagi, D. and Feramisco, J.R., 1985, Microinjection of the ras proteins into PC12 cells induces morphological differentiation. Cell 42:841.PubMedCrossRefGoogle Scholar
  2. Bookstein, R., Shew, J.-Y., Chen, P.-L., Scully, P. and Lee, W.-H., 1990, Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 247:712.PubMedCrossRefGoogle Scholar
  3. Bos, J.L., 1989, Ras oncogenes in human cancer. Cancer Res., 49:4682PubMedGoogle Scholar
  4. Caffrey, J.M., Brown A.M. and Schneider, M.D., 1987, Mitogens and oncogenes can block the induction of specific voltage-gated ion channels. Science 236, 570.PubMedCrossRefGoogle Scholar
  5. Capon, D.J., Chen E.Y., Levinson, A.D., Seeburg, P. and Goeddel, D.v., 1983, Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue. Nature 309:33.CrossRefGoogle Scholar
  6. Chen, P.-L., Chen, Y., Bookstein, R. and Lee, W.-H., 1990, Genetic mechanisms of tumor suppression by the human p53 gene. Science 250:1576.PubMedCrossRefGoogle Scholar
  7. Feinberg, A.P., Vogelstein, B., Droller, M.J., Baylin, S.B. and Nelkin, B.D., 1983, Mutation affecting the 12th amino acid of the c-Ha-ras oncogene product occurs infrequently in human cancer. Science 220:1175.PubMedCrossRefGoogle Scholar
  8. Feramisco, J.R., Clark, R., Wong, G., Arheim, N., Milley, R. and McCormick, F. Oncogene-induced cell transformation by antibodies specific for amino acid 12 of ras protein. Nature 314:639.CrossRefGoogle Scholar
  9. Field, J.K. and Spandidos, D.A. 1990, The role of ras and myc oncogenes in human solid tumors and their relevance in diagnosis and prognosis. Anticancer Res., 10:1PubMedGoogle Scholar
  10. Gambari, R. and Spandidos, D., 1986, Chinese hamster lung cells transformed with the human Ha-ras-1 oncogene: 5-azacytidine mediated induction of adipogenic conversion. Cell Biol. Int. Rep., 10: 173.CrossRefGoogle Scholar
  11. Guerrero, I., Pellicer, A. and Burstein, D.E., 1988, Dissociation of c-fos from ODC expression and neuronal differentiation in a PC12 subline stably transfected with an inducible N-ras oncogene. Biochem. Biophys. Res. Comm., 150:1185.PubMedCrossRefGoogle Scholar
  12. Hirakawa, T. and Ruley, H.E., 1988, Rescue of cells from ras oncogene-induced growth arrest by a second complementing oncogene. Proc. Natl. Acad. Sci. USA, 85:1519.PubMedCrossRefGoogle Scholar
  13. Huang, H.-J. S., Yee, J.-K., Shew, J.-Y., Chen, P.-L., Bookstein, R., Friedmann, T., Lee, E.Y.-H.P. and Lee, W.- H., 1988. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science, 242:1563.PubMedCrossRefGoogle Scholar
  14. Kakkanas, A. and Spandidos, D.A., 1990. In vitro and in vivo onco-suppressor activity of normal cells on cells transfected with the H-ras oncogene. In Vivo, 4:109.PubMedGoogle Scholar
  15. Kuzumaki, N. 1991, Suppression of ras-transformants, Anticancer Res. 11:313.PubMedGoogle Scholar
  16. Mulcahy, L.S., Smith, M.R. and Stacy, D.W., 1985, Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells. Nature, 318:73.CrossRefGoogle Scholar
  17. Muller, R., 1986, Proto-oncogenes and differentiation. TIBS, 11: 129.Google Scholar
  18. Noda, M., Kitayama, H., Matsuzaki, T, Sugimoto, Y., Okayama, H., Bassin, R.H., and Ikawa, Y., 1989, Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes. Proc. Natl. Acad. Sci. USA, 86:162.PubMedCrossRefGoogle Scholar
  19. Noda, M., Ko, M., Ogura, A., Liu D.-G., Amano, T. and Ikawa, Y., 1985, Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell line. Nature, 318: 73.PubMedCrossRefGoogle Scholar
  20. Olson, E.N., Spizz, G. and Tainsky, M.A., 1987, The oncogenic forms of N-ras prevent skeletal myoblast differentiation. Mol. Cell Biol., 7:2104.PubMedGoogle Scholar
  21. Ridley, A.J., Paterson, H.F., Noble, M. and Land, H., 1988, Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwan cell transformation. EMBO J., 7:1635.PubMedGoogle Scholar
  22. Santos, E., Martin-Zanca, D., Reddy, E.P., Pierotti, M.A., Della Porta, G. and Barbacid, M., 1984, Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissues of the same patient. Science, 223:661.PubMedCrossRefGoogle Scholar
  23. Spandidos, D.A. 1986. The human T24 Ha-rasl oncogene: A study of the effects of overexpression of the mutated ras gene product in rodent cells. Anticancer Res., 8:259.Google Scholar
  24. Spandidos, D.A. 1989, The effect of exogenous human ras and myc oncogenes in morphological differentiation of the rat pheochromocytoma PC12 cells. Int. J. Devl. Neurosci., 7:1CrossRefGoogle Scholar
  25. Spandidos, D.A. and Anderson, M.L.M.,1987, A study of the mechanism of carcinogenesis by gene transfer of oncogenes into mammalian cells. Mutat. Res., 185:271.PubMedGoogle Scholar
  26. Spandidos, D.A. and Anderson, M.L.M., 1989, Oncogenes and oncosuppressor genes: their involvement in cancer. J. Pathol., 157:1.PubMedCrossRefGoogle Scholar
  27. Spandidos, D.A., Frame M. and Wilkie, N.M., 1990. Expression of the normal H-ras gene can suppress the transformed and mutant ras genes. Anticancer Res. 10:1543.PubMedGoogle Scholar
  28. Spandidos, D.A. and Wilkie, N.M., 1988, The normal human H-ras1 gene can act as an onco-suppressor. Br. J. Cancer 58., Suppl IX: 67.Google Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Demetrios A. Spandidos
    • 1
    • 2
  1. 1.Institute of Biological Research and BiotechnologyHellenic Research FoundationAthensGreece
  2. 2.Medical SchoolUniversity of CreteHeraklionGreece

Personalised recommendations